🇺🇸 FDA
Patent

US 7247303

Selected antibody CDRs for binding to aminophospholipids

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 7247303 (Selected antibody CDRs for binding to aminophospholipids) held by The Board of Regents of the University of Texas System expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/505, A61K39/395, A61K39/39558, A61K47/62